argenx SE (ARGX)
NASDAQ: ARGX
· Real-Time Price · USD
800.00
8.41 (1.06%)
At close: Oct 03, 2025, 3:59 PM
791.25
-1.09%
After-hours: Oct 03, 2025, 06:10 PM EDT
1.06% (1D)
Bid | 791.18 |
Market Cap | 48.93B |
Revenue (ttm) | 3.66B |
Net Income (ttm) | 1.37B |
EPS (ttm) | 19.63 |
PE Ratio (ttm) | 40.75 |
Forward PE | 32.67 |
Analyst | Buy |
Dividends | n/a |
Ask | 806 |
Volume | 352,311 |
Avg. Volume (20D) | 401,152 |
Open | 798.35 |
Previous Close | 791.59 |
Day's Range | 790.65 - 803.58 |
52-Week Range | 510.06 - 803.74 |
Beta | 0.04 |
Ex-Dividend Date | n/a |
About ARGX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ARGX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ARGX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecastsargenx SE is scheduled to release its earnings on
Oct 30, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 days ago
+4.04%
Argenx shares are trading higher after Morgan Stan...
Unlock content with
Pro Subscription
1 month ago
+4.54%
Argenx shares are trading higher after Piper Sandler raised its price target on the stock from $750 to $820.

1 month ago · seekingalpha.com
Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic ShiftsInsmed, Intuitive Surgical, and IDEXX Laboratories were top contributors, driven by strong drug pipelines, innovation, and robust financial results. We exited UnitedHealth Group due to earnings misses...